Gero Raises $6M for Physics-Powered GenAI Biotech
What You Should Know:
Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round.This funding round positions Gero to continue internal drug development programs, grow its…
Continue Reading